International Standard
ISO 20012:2026
Biotechnology — Biobanking — Requirements for human natural killer cells derived from pluripotent stem cells
Reference number
ISO 20012:2026
Edition 1
2026-02
Preview
ISO 20012:2026
86065
Indisponible en français
Publiée (Edition 1, 2026)

ISO 20012:2026

ISO 20012:2026
86065
Langue
Format
CHF 135

Résumé

This document specifies requirements for the biobanking of human natural killer (NK) cells derived from human pluripotent stem cells (hPSCs), including the requirements for the differentiaton, culture, characterization, quality control, storage, thawing and transport of NK cells.

Requirements for the collection of biological source material, the transport to and reception of biological source material and hPSCs at the biobank, as well as the establishment, expansion and QC of hPSCs are covered in ISO 24603.

This document is applicable to all organizations performing biobanking of human NK cells used for research and development in the life sciences.

This document does not apply to human NK cells for the purpose of in vivo application in humans, clinical applications or therapeutic use.

NOTE            International, national or regional regulations or requirements or multiple of them can also apply to specific topics covered in this document.

Informations générales

  •  : Publiée
     : 2026-02
    : Norme internationale publiée [60.60]
  •  : 1
  • ISO/TC 276
    07.080 
  • RSS mises à jour

Cycle de vie

Vous avez une question?

Consulter notre Aide et assistance